tetracycline and Schizophrenia

Schizophrenia is a devastating disorder. Despite the advance in research techniques in the last couple of decades, the pathogenesis of the disorder still remains poorly understood. Given the lack of pathognomonic feature of the disease and difficulty to analyze molecular pathways in patients, animal models have been instrumental in advancing our understanding of the disease. Recent progress in genetics has identified candidate susceptibility genes for schizophrenia, and generation of new genetic animal models has begun to provide valuable insights into the disease development. However, the complex neurodevelopmental and heterogeneous nature of schizophrenia still poses tremendous challenges for creating credible mouse models. In this review, we will discuss how current genetic systems of temporal and conditional regulation of gene expression have shed lights on the functions of the candidate genes in mouse models of schizophrenia. We also consider the strength and weaknesses of each model. We will argue that further development of more sophisticated genetic animal models is crucial for clarifying the unknowns of schizophrenia.

Topics: Animals; Disease Models, Animal; Estrogen Receptor alpha; Gene Expression Regulation; Gene Transfer Techniques; GTP-Binding Proteins; Humans; Mice; Mice, Transgenic; Nerve Tissue Proteins; Receptors, Dopamine D2; Schizophrenia; Tetracycline

Topics: Acetone; Animals; Brain Chemistry; Chromatography, Paper; Cyclohexanes; Dinitrophenols; Female; Humans; Intestines; Male; Methods; Microchemistry; Piperidines; Schizophrenia; Spectrophotometry; Swine; Tetracycline; Time Factors

Topics: Adrenal Cortex Hormones; Agranulocytosis; Anti-Bacterial Agents; Oxytetracycline; Penicillins; Schizophrenia; Streptomycin; Tetracycline; Thioridazine; Thrombocytopenia; Toxicology